Glucocorticoids and muscle catabolism

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 2, Issue 3, 1999, Pages 201-205

  Hasselgren, Per Olof ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYTOKINE; GLUCOCORTICOID; GLUTAMATE AMMONIA LIGASE; MULTIENZYME COMPLEX; PROTEASOME; UBIQUITIN;

AGING; ANIMAL; CUSHING SYNDROME; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MUSCLE; PATHOPHYSIOLOGY; REVIEW;

AGING; ANIMALS; CUSHING SYNDROME; CYSTEINE ENDOPEPTIDASES; CYTOKINES; GENE EXPRESSION; GLUCOCORTICOIDS; GLUTAMATE-AMMONIA LIGASE; HUMANS; MULTIENZYME COMPLEXES; MUSCLES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITINS;

EID: 0033127892     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199905000-00002     Document Type: Article

References (35)

1. Odedra BR, Bates PC, Millward DJ. Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver. Biochem J 1983; 214:617-627.
2. Kayali AG, Young VR, Goodman MN. Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am J Physiol 1987; 252:E621-626.
3. Auclair D, Garrel DR, Zerouala AC, Ferland LH. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am J Physiol 1997; 272:C1007-1016. This study presents convincing evidence that glucocorticoids upregulate mRNA levels for several components of the ubiquitin-proteasome proteolytic pathway.
4. Tiao G, Lieberman MA, Fischer JE, Hasselgren PO. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am J Physiol 1997; 272:R849-856.
5. Fang CH, Li BG, Tiao G, Wang JJ, Fischer JE, Hasselgren PO. The molecular regulation of protein breakdown following burn injury is different in fast- and slow-twitch skeletal muscle. Int J Mol Med 1998; 1:163-169.
6. Wang L, Luo GJ, Wang JJ, Hasselgren PO. Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes. Shock 1998; 10:298-306. The results of this study show that there is not an absolute correlation between mRNA levels for proteolytic enzymes and proteolytic activity.
7. Hall-Angerås M, Angerås U, Zamir O, Hasselgren PO, Fischer JE. Effect of the glucocorticoid receptor antagonist RU 38486 on muscle protein breakdown in sepsis. Surgery 1991; 109:468-473.
8. Tiao G, Fagan J, Roegner V, Lieberman M, Wang JJ, Fischer JE, Hasselgren PO. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 1996; 97:339-348.
9. Almon RR, Dubois DC. Fiber-type discrimination in disuse and glucocorticoid-induced atrophy. Med Sci Sports Exerc 1990; 22:304-311.
10. Ding X, Price SR, Bailey JL, Mitch WE. Cellular mechanisms controlling protein degradation in catabolic states. Miner Electrolyte Metab 1997; 23:194-197.
11. Franz M, Horl WH. Protein catabolism in acute renal failure. Miner Electrolyte Metab 1997; 23:189-193.
12. Price SR, England BK, Bailey JL, Van Vreede K, Mitch WE. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 1994; 267:C955-960.
13. May RC, Bailey JL, Mitch WE, Masud T, England BK. Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 1996; 49:679-683.
14. Isozaki U, Mitch WE, England BK, Price SR. Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H-1 myocytes require an interaction between glucocorticoids and acidification. Proc Natl Acad Sci USA 1996; 93:1967-1971.
15. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993; 264:E668-676.
16. Fang CH, Tiao G, James JH, Ogle CK, Fischer JE, Hasselgren PO. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Coll Surg 1995; 180:161-170.
17. Fang CH, James JH, Ogle CK, Fischer JE, Hasselgren PO. Influence of burn injury on protein metabolism in different types of skeletal muscle tissue and the role of glucocorticoids. J Am Coll Surg 1995; 180:33-42.
18. MacLennan PA, Brown RA, Rennie MJ. A positive relationship between protein synthesis rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS Lett 1987; 215:187-191.
19. MacLennan PA, Smith K, Weryk B, Watt P, Rennie MJ. Inhibition of protein breakdown in perfused rat skeletal muscle. FEBS Lett 1988; 237:133-136.
20. Fang CH, James JH, Fischer JE, Hasselgren PO. Is muscle protein turnover regulated by intracellular glutamine during sepsis? J Parenter Enter Nutr 1995; 19:279-285.
21. Abcouwer SF, Bode BP, Souba WW. Glucocorticoids regulate rat glutamine synthetase expression in a tissue-specific manner. J Surg Res 1995; 59:59-65.
22. Meynial-Denis D, Mignou M, Miri A, Imbert J, Aurousseau E, Taillandier D, et al. Glutamine synthetase induction by glucocorticoids is preserved in skeletal muscle of aged rats. Am J Physiol 1996; 271:E1061-1066.
23. Lukasiewicz GC, Souba WW, Abcouwer SF. Induction of muscle glutamine synthetase gene expression during endotoxemia is adrenal gland dependent. Shock 1997; 7:332-338.
24. Chang HR, Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parenter Enter Nutr 1998; 22:156-166. An extensive review of the mediators (including cytokines and glucocorticoids) of sepsis- and injury-induced muscle cachexia.
25. Gwosdow AR, Kumar MSA, Bode HH. Interleukin-1 stimulation of hypothalamic-pituitary-adrenal axis. Am J Physiol 1990; 258:E65-70.
26. Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC. Dexamethasone inhibition of interleukin-1β production by human monocytes. J Clin Invest 1988; 81:237-244.
27. Baumann H, Richards C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin-1, and glucocorticoids for regulation of acute phase proteins in human hepatoma (HepG2) cells. J Immunol 1987; 139:4122-4128.
28. Hall-Angerås M, Angerås U, Zamir O, Hasselgren PO, Fischer JE. Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis. Surgery 1990; 108:460-466.
29. Mealy K, van Lanschot JJB, Robinson BG, Ramos J, Wilmore DW. Are the catabolic effects of tumor necrosis factor mediated by glucocorticoids? Arch Surg 1990; 125:42-48.
30. Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE. Tumor necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm 1992; 1:247-250.
31. Dardeyet D, Sornet C, Taillandier D, Savary I, Attaix D, Grizard J. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J Clin Invest 1995; 96:2113-2119.
32. Savary I, Debras E, Dardevet D, Sornet C, Capitan P, Prugnaud J, et al. Effect of glucocorticoid excess on skeletal muscle and heart protein synthesis in adult and old rats. Br J Nutr 1998; 79:297-304.
33. Dardevet D, Sornet C, Savary I, Debras E, Patureau-Mirand P, Grizard J. Glucocorticoid effects on insulin- and IGF-1-regulated muscle protein metabolism during aging. J Endocrinol 1998; 156:83-89.
34. Ralliere C, Tauveron I, Taillandier D, Guy L, Boiteux JP, Giraud B, et al. Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing's syndrome patients. J Clin Endocrinol Metab 1997; 82:3161-3164. An important study because it investigates for the first time the correlation between glucocorticoid-induced muscle atrophy and gene expression of the ubiquitin-proteasome pathway in human muscle tissue.
35. Bowes SB, Benn JJ, Scobie IN, Umpleby AM, Lowy C, Sonksen PH. Leucine metabolism in patients with Cushing's syndrome before and after successful treatment. Clin Endocrinol 1993; 39:591-598.